Paper34735653
Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities.
Hleihel R and 5 others. Curr Oncol Rep, 2021. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities. Papers, record 34735653. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34735653
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Immunological | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Leukemia-Lymphoma, Adult T-Cell | Major topic |
| Antibodies, Monoclonal, Humanized | |
| Humans | |
| Prognosis |
Source PubMed
References134
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9864171 | Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells. | Blood | 1999 | https://conductscience.org/library/papers/9864171 | PubMed |
| 2 | 12627852 | Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109). | Int J Hematol | 2003 | https://conductscience.org/library/papers/12627852 | PubMed |
| 3 | 18948574 | Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25. | Blood | 2009 | https://conductscience.org/library/papers/18948574 | PubMed |
| 4 | 20479287 | Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. | Blood | 2010 | https://conductscience.org/library/papers/20479287 | PubMed |
| 5 | 1751370 | Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). | Br J Haematol | 1991 | https://conductscience.org/library/papers/1751370 | PubMed |
| 6 | 25029232 | Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP. | Bone Marrow Transplant | 2014 | https://conductscience.org/library/papers/25029232 | PubMed |
| 7 | 27621400 | Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/27621400 | PubMed |
| 8 | 23962110 | The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma. | Retrovirology | 2013 | https://conductscience.org/library/papers/23962110 | PubMed |
| 9 | 17968021 | VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17968021 | PubMed |
| 10 | 27322308 | HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ. | Viruses | 2016 | https://conductscience.org/library/papers/27322308 | PubMed |
| 11 | 26735971 | HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT). | PLoS Pathog | 2016 | https://conductscience.org/library/papers/26735971 | PubMed |
| 12 | 19411628 | Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL). | Blood | 2009 | https://conductscience.org/library/papers/19411628 | PubMed |
| 13 | 15522654 | New therapeutic approaches for adult T-cell leukaemia. | Lancet Oncol | 2004 | https://conductscience.org/library/papers/15522654 | PubMed |
| 14 | 29545256 | Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States. | Blood Adv | 2018 | https://conductscience.org/library/papers/29545256 | PubMed |
| 15 | 7492783 | Characterization of T cells immortalized by Tax1 of human T-cell leukemia virus type 1. | Blood | 1995 | https://conductscience.org/library/papers/7492783 | PubMed |
| 16 | 31617432 | Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies. | Leuk Lymphoma | 2020 | https://conductscience.org/library/papers/31617432 | PubMed |
| 17 | 20585095 | Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20585095 | PubMed |
| 18 | 21505188 | Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes. | Blood | 2011 | https://conductscience.org/library/papers/21505188 | PubMed |
| 19 | 22312108 | Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22312108 | PubMed |
| 20 | 21228036 | Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy. | Haematologica | 2011 | https://conductscience.org/library/papers/21228036 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42511509 | Investigating the Mechanisms Underlying Cell Death Induction by a Tributyltin Molecule in HTLV-1-Infected Cells Dependent or Not on IL-2 as a Growth Factor. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511509 | PubMed |
| 42240309 | HTLV-1 Tax and HBZ cooperatively promote leukemogenesis through miR-155-mediated PTEN suppression and PI3K-Akt activation. | J Virol | 2026 | https://conductscience.org/library/papers/42240309 | PubMed |
| 41599396 | Cytotoxic Effects of a Triorganotin Derivative on HTLV-1-Infected Cells at Different Immortalization/Transformation Stages In Vitro. | Molecules | 2026 | https://conductscience.org/library/papers/41599396 | PubMed |
| 40551258 | Unveiling the anticancer potential of SGLT-2 inhibitors: mechanisms and prospects in clinical oncology-a narrative review. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40551258 | PubMed |
| 39633427 | Evaluation of ALKBH2 and ALKBH3 gene regulation in patients with adult T-cell leukemia/lymphoma. | Virol J | 2024 | https://conductscience.org/library/papers/39633427 | PubMed |
| 39008152 | Peptides for microbe-induced cancers: latest therapeutic strategies and their advanced technologies. | Cancer Metastasis Rev | 2024 | https://conductscience.org/library/papers/39008152 | PubMed |
| 37892225 | Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive Review. | Biomolecules | 2023 | https://conductscience.org/library/papers/37892225 | PubMed |
| 37531001 | Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo. | J Neurovirol | 2025 | https://conductscience.org/library/papers/37531001 | PubMed |
| 37137914 | Primary cells from patients with adult T cell leukemia/lymphoma depend on HTLV-1 Tax expression for NF-κB activation and survival. | Blood Cancer J | 2023 | https://conductscience.org/library/papers/37137914 | PubMed |
| 36428851 | Comparative Genomic Hybridization and Transcriptome Sequencing Reveal Genes with Gain in Acute Lymphoblastic Leukemia: JUP Expression Emerges as a Survival-Related Gene. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/36428851 | PubMed |
| 35935975 | Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia. | Front Immunol | 2022 | https://conductscience.org/library/papers/35935975 | PubMed |
| 35686099 | The Roles of FHL3 in Cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/35686099 | PubMed |
| 35631768 | Prediction of the Adult T-Cell Leukemia Inhibitory Activity of Blueberry Leaves/Stems Using Direct-Injection Electron Ionization-Mass Spectrometry Metabolomics. | Plants (Basel) | 2022 | https://conductscience.org/library/papers/35631768 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HBZ | 3050 | PubTator's text mining | https://conductscience.org/library/genes/3050 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34735653
GET https://conductscience.org/api/papers/v1/34735653/references?page=2